Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GSK

FTSE 100 Live 17 September: Food prices blow, Barratt Redrow flags Budget delay risk

The UK’s annual rate of inflation has stayed at the highest level since January 2024.

Evening Standard

UK set on resolving standoff with big pharma, science minister says

UK set on resolving standoff with big pharma, science minister says

Patrick Vallance says relations must improve and NHS has to reverse decline in drugs investment

The Guardian - UK

Big pharma firms have paused nearly £2bn in UK investments this year

Big pharma firms have paused nearly £2bn in UK investments this year

Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.

China pharma deals threaten U.S. biotech

The strategy comes as China has become a powerhouse in AI, chemistry and other areas.

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?

Wave Life Sciences Ltd. (NASDAQ:WVE) stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.

Shingles vaccine could lower risk of heart attack and stroke, study finds

Adults vaccinated against shingles had an 18 per cent lower risk of serious heart problems, the analysis found.

inkl

Read news from The Economist, FT, and more,
with one subscription

FTSE 100 edges down despite hopes of end to Russia-Ukraine war

FTSE 100 edges down despite hopes of end to Russia-Ukraine war

Evening Standard

GSK to be paid up to £370 million after patent row settles in US

GSK to be paid up to £370 million after patent row settles in US

CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on Thursday.

Evening Standard

FTSE 100 ends flat ahead of likely US rate hold

FTSE 100 ends flat ahead of likely US rate hold

The FTSE 100 index closed up just 0.62 of a point at 9,136.94.

Evening Standard

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 guidance.

Business news live: FTSE 100 reaction as HSBC sees profits drop, Nationwide launches benefits line

Business news live: FTSE 100 reaction as HSBC sees profits drop, Nationwide launches benefits line

Stock market news and latest business and finance updates from Wednesday

The Independent UK

After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact

After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact

Chinese biotech company Hengrui Pharma partnered with GSK plc (NYSE:GSK) on Monday to develop up to 12 medicines.

GSK's Blood Cancer Drug Review Extended As FDA Seeks More Data

GSK's Blood Cancer Drug Review Extended As FDA Seeks More Data

The US Food and Drug Administration (FDA) on Wednesday extended the review period for the Biologics License Application (BLA) for GSK plc’s (NYSE:GSK) Blenrep combinations for relapsed or refractory multiple myeloma patients who have received at least one prior line of therapy.

Get all your
news in one place.

100's of premium titles.
One news app.

GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning

The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) combinations.

GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults

On Monday, the U.S. Food and Drug Administration (FDA) agreed to review GSK plc’s (NYSE:GSK) application to extend the indication of Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults aged 18-49 who are at increased risk.

Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony

The Delaware Supreme Court has overturned a lower court’s decision that allowed expert testimony supporting plaintiffs’ claims in a high-profile case alleging that Zantac, or its generic ranitidine, can cause cancer.

Evening Standard

Weak retail sales and falls in key oil and drug stocks stifle FTSE 100

The FTSE 100 index closed down 17.15 points, 0.2%, at 8,774.65.

Get all your
news in one place.

100's of premium titles.
One news app.

From AI to aerospace: Europe's most innovative companies shaping tomorrow

For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the standouts that are driving progress with success.

Queens of influence: Meet the women shaping Europe's future

In its 28th year, the annual MPW list recognizes 100 women leading major global companies. This year, 21 listees are at the helm of European companies.

The UK is rolling out a world-first vaccine for gonorrhoea. What about the rest of Europe?

The UK will offer a vaccine originally intended to prevent meningitis, which is caused by a bacteria with a similar genetic profile to the one that causes gonorrhoea.

Evening Standard

British boss of US healthcare giant UnitedHealth quits for ‘personal reasons’

The move comes five months after one of the company’s top executives was killed after being shot as he walked to an investor conference in New York.

The Independent UK

Tariff turmoil prompts cloudy forecasts from companies for the year ahead

Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they try to navigate a global trade system severely shaken by a stark shift in U.S. policy

Evening Standard

Wall Street falls while FTSE 100 regains losses after US economy shrinks

The American economy contracted by 0.3% in the first three months of the year amid Donald Trump’s threats of sweeping trade tariffs.

Evening Standard

Drugs giant GSK ‘well positioned’ to absorb potential US tariffs

It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines.

1 … 4 5 6 7

People

207,198 stories

Emmanuel Macron

Robert F. Kennedy Jr

Patrick Vallance

Robert Kennedy, Jr.

Stephen Hemsley

Charles Williams

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Supreme Court

British Petroleum

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

406,417 stories

146,251 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play